Abstract
The evidence that genetic factors are involved in risk and outcome of pneumonia is clear. Most likely genetic factors play a role in risk of VAP in a subgroup of patients as well. In the past years, a large number of polymorphisms in diverse inflammatory genes have been identified as candidates to explain genetic variability in susceptibility to pulmonary infections and its adverse outcomes. Despite the number of variations already discovered, the clinical implications remain unclear. The need to advance from simple statistical significance to biological understanding is clear. Future welldesigned studies will need to address the extremely complex gene-gene and gene-environment interactions, particularly in ventilator-associated pneumonia. Large collaborative efforts creating exquisitely detailed (both clinically and microbiologically) cohorts are required to establish this rigorous approach and produce replicable results. Complementary translational studies of the functionality of the genetic variations identified are needed. Despite the criticisms raised, early examples of pharmacogenetics aspects of infectious diseases have been shown. Hopefully this renewed approach will take a step further in accomplishing the enormous promise of genetics and personalized medicine.
Keywords: Ventilator-associated pneumonia, sepsis, polymorphisms, genetic risk
Current Respiratory Medicine Reviews
Title: Association of Genetic Variation with Pneumonia
Volume: 6 Issue: 1
Author(s): Anke H.W. Bruns and R. G. Wunderink
Affiliation:
Keywords: Ventilator-associated pneumonia, sepsis, polymorphisms, genetic risk
Abstract: The evidence that genetic factors are involved in risk and outcome of pneumonia is clear. Most likely genetic factors play a role in risk of VAP in a subgroup of patients as well. In the past years, a large number of polymorphisms in diverse inflammatory genes have been identified as candidates to explain genetic variability in susceptibility to pulmonary infections and its adverse outcomes. Despite the number of variations already discovered, the clinical implications remain unclear. The need to advance from simple statistical significance to biological understanding is clear. Future welldesigned studies will need to address the extremely complex gene-gene and gene-environment interactions, particularly in ventilator-associated pneumonia. Large collaborative efforts creating exquisitely detailed (both clinically and microbiologically) cohorts are required to establish this rigorous approach and produce replicable results. Complementary translational studies of the functionality of the genetic variations identified are needed. Despite the criticisms raised, early examples of pharmacogenetics aspects of infectious diseases have been shown. Hopefully this renewed approach will take a step further in accomplishing the enormous promise of genetics and personalized medicine.
Export Options
About this article
Cite this article as:
Bruns H.W. Anke and Wunderink G. R., Association of Genetic Variation with Pneumonia, Current Respiratory Medicine Reviews 2010; 6 (1) . https://dx.doi.org/10.2174/157339810790820377
DOI https://dx.doi.org/10.2174/157339810790820377 |
Print ISSN 1573-398X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6387 |
Call for Papers in Thematic Issues
Exposure to PM2.5 components is associated with respiratory diseases
Through continuous research on the relationship between risk factors and health, it has been found that air pollution, especially atmospheric particulate matter pollution, has become one of the main sources of global disease burden. From 1990 to 2022, the concentration of atmospheric particulate matter pollution has increased by more than ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Cerebrovascular Endothelin Receptor Upregulation in Cerebral Ischemia
Current Vascular Pharmacology Anti-Viral Agents in Neurodegenerative Disorders: New Paradigm for Targeting Alzheimer’s Disease
Recent Patents on Anti-Infective Drug Discovery Caring for HIV-Infected Patients in the ICU in The Highly Active Antiretroviral Therapy Era
Current HIV Research Tuberculostatic Drugs Targeting Infections of the Central Nervous System
Anti-Infective Agents Emerging Therapies in Relapsing-Remitting Multiple Sclerosis
Reviews on Recent Clinical Trials Recent Patents in Cell Therapy for Amyotrophic Lateral Sclerosis
Recent Patents on Regenerative Medicine The Protein Therapy of Kallikrein in Cerebral Ischemic Reperfusion Injury
Current Medicinal Chemistry Traumatic Brain Injury and Blood-Brain Barrier Cross-Talk
CNS & Neurological Disorders - Drug Targets Polysaccharide Production in Pilot Scale Bioreactor Cultivations of Neisseria meningitidis Serogroup C
Current Biochemical Engineering (Discontinued) Targeting Cancer Stem Cells with Repurposed Drugs to Improve Current Therapies
Recent Patents on Anti-Cancer Drug Discovery Neuroinflammation, Microglia and Mast Cells in the Pathophysiology of Neurocognitive Disorders: A Review
CNS & Neurological Disorders - Drug Targets Oncolytic Coxsackievirus and the Mechanisms of its Effects on Cancer: A Narrative Review
Current Cancer Therapy Reviews Viral Myocarditis and Dilated Cardiomyopathy: Etiology and Pathogenesis
Current Pharmaceutical Design New Advances in Infant Feeding: New Products and Novel Technologies
Recent Patents on Food, Nutrition & Agriculture Enhanced Efficacy of DNA Vaccines Against an Intracellular Bacterial Pathogen by Genetic Adjuvants
Current Pharmaceutical Biotechnology Mother-to-Child Transmission Outcomes of HIV-Exposed Infants Followed Up in Jos North-Central Nigeria
Current HIV Research Role of Progesterone in Human Astrocytomas Growth
Current Topics in Medicinal Chemistry Therapeutic Implications of Tocilizumab, A Humanized Anti-Interleukin-6 Receptor Antibody, for Various Immune-Mediated Diseases: An Update Review
Current Rheumatology Reviews Retinoic Acid and the Gut Microbiota in Alzheimer’s Disease: Fighting Back-to-Back?
Current Alzheimer Research ADAM17 as a Therapeutic Target in Multiple Diseases
Current Pharmaceutical Design